Scientific Sessions 2025  /  Cardiometabolic and Lifestyle Interventions for AF    /  Discussant: DECAF
Logo

American Heart Association

  67
  0

Final ID:

Discussant: DECAF

  • Russo, Andrea  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
    • Author Disclosures:
    Andrea Russo: DO have relevant financial relationships ; Research Funding (PI or named investigator):Abbott, Bayer, Boston Scientific, Medtronic and Novartis:Active (exists now) ; Royalties/Patent Beneficiary:Royalties (writing/editing): UpToDate:Active (exists now) ; Other (please indicate in the box next to the company name):Fellowship support: Medtronic:Active (exists now) ; Consultant:Abbott, Atricure, Bayer, Sanofi:Past (completed) ; Consultant:Biosense Webster, Biotronik, Boston Scientific, Medtronic, Orchestra BioMed, PaceMate :Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Cardiometabolic and Lifestyle Interventions for AF  

Sunday, 11/09/2025 , 08:00AM - 09:15AM

Late-Breaking Science

More abstracts on this topic:
The Does Eliminating Coffee Avoid Fibrillation (DECAF) Trial

Wong Christopher, Moss Joshua, Gerstenfeld Edward, Tseng Zian, Hsia Henry, Lee Randall, Olgin Jeffrey, Vedantham Vasanth, Scheinman Melvin, Lee Catherine, Sanders Prashanthan, Cheung Christopher, Marcus Gregory, Montenegro Gabrielle, Oo Hannah, Pena Isabella, Tang Janet, Tu Samuel, Wall Grace, Dewland Thomas

Discussant: DARE-AF

Yancy Clyde

More abstracts from these authors:
Just Five More Minutes! Devices, AF and AHRE's - New data, new Guidelines

Indik Julia, Russo Andrea

Panelist

Russo Andrea

You have to be authorized to contact abstract author. Please, Login
Not Available